Literature DB >> 20971628

Bryostatins: biological context and biotechnological prospects.

Amaro E Trindade-Silva1, Grace E Lim-Fong, Koty H Sharp, Margo G Haygood.   

Abstract

Bryostatins are a family of protein kinase C modulators that have potential applications in biomedicine. Found in miniscule quantities in a small marine invertebrate, lack of supply has hampered their development. In recent years, bryostatins have been shown to have potent bioactivity in the central nervous system, an uncultivated marine bacterial symbiont has been shown to be the likely natural source of the bryostatins, the bryostatin biosynthetic genes have been identified and characterized, and bryostatin analogues with promising biological activity have been developed and tested. Challenges in the development of bryostatins for biomedical and biotechnological application include the cultivation of the bacterial symbiont and heterologous expression of bryostatin biosynthesis genes. Continued exploration of the biology as well as the symbiotic origin of the bryostatins presents promising opportunities for discovery of additional bryostatins, and new functions for bryostatins.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971628      PMCID: PMC4497553          DOI: 10.1016/j.copbio.2010.09.018

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  39 in total

Review 1.  The chemistry and biology of the bryostatin antitumour macrolides.

Authors:  Karl J Hale; Marc G Hummersone; Soraya Manaviazar; Mark Frigerio
Journal:  Nat Prod Rep       Date:  2002-08       Impact factor: 13.423

2.  Aquaculture of three phyla of marine invertebrates to yield bioactive metabolites: process developments and economics.

Authors:  Dominick Mendola
Journal:  Biomol Eng       Date:  2003-07

Review 3.  Approaches to identify, clone, and express symbiont bioactive metabolite genes.

Authors:  Mark Hildebrand; Laura E Waggoner; Grace E Lim; Katherine H Sharp; Christian P Ridley; Margo G Haygood
Journal:  Nat Prod Rep       Date:  2003-12-15       Impact factor: 13.423

4.  Identification of sibling species of the bryozoan Bugula neritina that produce different anticancer bryostatins and harbor distinct strains of the bacterial symbiont "Candidatus Endobugula sertula".

Authors:  S K Davidson; M G Haygood
Journal:  Biol Bull       Date:  1999-06       Impact factor: 1.818

5.  Evidence for the biosynthesis of bryostatins by the bacterial symbiont "Candidatus Endobugula sertula" of the bryozoan Bugula neritina.

Authors:  S K Davidson; S W Allen; G E Lim; C M Anderson; M G Haygood
Journal:  Appl Environ Microbiol       Date:  2001-10       Impact factor: 4.792

6.  Recombinational transfer of 100-kilobase genomic DNA to plasmid in Bacillus subtilis 168.

Authors:  K Tsuge; M Itaya
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

Review 7.  Tracing the evolution of gene loss in obligate bacterial symbionts.

Authors:  Nancy A Moran
Journal:  Curr Opin Microbiol       Date:  2003-10       Impact factor: 7.934

8.  Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice.

Authors:  René Etcheberrigaray; Mathew Tan; Ilse Dewachter; Cuno Kuipéri; Ingrid Van der Auwera; Stefaan Wera; Lixin Qiao; Barry Bank; Thomas J Nelson; Alan P Kozikowski; Fred Van Leuven; Daniel L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

9.  Cryptic species, cryptic endosymbionts, and geographical variation in chemical defences in the bryozoan Bugula neritina.

Authors:  Tamara M McGovern; Michael E Hellberg
Journal:  Mol Ecol       Date:  2003-05       Impact factor: 6.185

10.  Potent cytotoxins produced by a microbial symbiont protect host larvae from predation.

Authors:  Nicole Lopanik; Niels Lindquist; Nancy Targett
Journal:  Oecologia       Date:  2004-01-28       Impact factor: 3.225

View more
  41 in total

1.  Translating Nature's Library: The Bryostatins and Function-Oriented Synthesis.

Authors:  Paul A Wender; Brian A Loy; Adam J Schrier
Journal:  Isr J Chem       Date:  2011-03-24       Impact factor: 3.333

2.  The Global Invertebrate Genomics Alliance (GIGA): developing community resources to study diverse invertebrate genomes.

Authors:  Heather Bracken-Grissom; Allen G Collins; Timothy Collins; Keith Crandall; Daniel Distel; Casey Dunn; Gonzalo Giribet; Steven Haddock; Nancy Knowlton; Mark Martindale; Mónica Medina; Charles Messing; Stephen J O'Brien; Gustav Paulay; Nicolas Putnam; Timothy Ravasi; Greg W Rouse; Joseph F Ryan; Anja Schulze; Gert Wörheide; Maja Adamska; Xavier Bailly; Jesse Breinholt; William E Browne; M Christina Diaz; Nathaniel Evans; Jean-François Flot; Nicole Fogarty; Matthew Johnston; Bishoy Kamel; Akito Y Kawahara; Tammy Laberge; Dennis Lavrov; François Michonneau; Leonid L Moroz; Todd Oakley; Karen Osborne; Shirley A Pomponi; Adelaide Rhodes; Scott R Santos; Nori Satoh; Robert W Thacker; Yves Van de Peer; Christian R Voolstra; David Mark Welch; Judith Winston; Xin Zhou
Journal:  J Hered       Date:  2014 Jan-Feb       Impact factor: 2.645

Review 3.  Microbial natural products: molecular blueprints for antitumor drugs.

Authors:  Lesley-Ann Giddings; David J Newman
Journal:  J Ind Microbiol Biotechnol       Date:  2013-09-03       Impact factor: 3.346

4.  Marine natural products: a new wave of drugs?

Authors:  Rana Montaser; Hendrik Luesch
Journal:  Future Med Chem       Date:  2011-09       Impact factor: 3.808

5.  Design, synthesis, and evaluation of potent bryostatin analogs that modulate PKC translocation selectivity.

Authors:  Paul A Wender; Jeremy L Baryza; Stacey E Brenner; Brian A DeChristopher; Brian A Loy; Adam J Schrier; Vishal A Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-17       Impact factor: 11.205

Review 6.  Bioactive Compounds from Marine Heterobranchs.

Authors:  Conxita Avila; Carlos Angulo-Preckler
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

7.  Total synthesis of bryostatin 9.

Authors:  Paul A Wender; Adam J Schrier
Journal:  J Am Chem Soc       Date:  2011-05-27       Impact factor: 15.419

8.  Inhibition of Chikungunya Virus-Induced Cell Death by Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway.

Authors:  Daryl Staveness; Rana Abdelnabi; Katherine E Near; Yu Nakagawa; Johan Neyts; Leen Delang; Pieter Leyssen; Paul A Wender
Journal:  J Nat Prod       Date:  2016-02-22       Impact factor: 4.050

9.  Function Oriented Synthesis: Preparation and Initial Biological Evaluation of New A-Ring-Modified Bryologs.

Authors:  Paul A Wender; Jenny Reuber
Journal:  Tetrahedron       Date:  2011-12-23       Impact factor: 2.457

Review 10.  Recent advances in the biosynthesis of unusual polyketide synthase substrates.

Authors:  Lauren Ray; Bradley S Moore
Journal:  Nat Prod Rep       Date:  2016-02       Impact factor: 13.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.